Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion

Journal of Urology

Volumn 156, Issue 3, 1996, Pages 1071-1076

  Esrig, David ^b   Freeman, John A ^a   Elmajian, Donald A ^b   Stein, John P ^b   Chen, Su Chiu ^b   Groshen, Susan ^b   Simoneau, Anne ^b   Skinner, Eila C ^b   Lieskovsky, Gary ^b   Boyd, Stuart D ^b   Cote, Richard J ^b   Skinner, Donald G ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

bladder; carcinoma, transitional cell; cystectomy; prostate

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CYSTECTOMY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; TRANSITIONAL CELL CARCINOMA; URETHRA TUMOR;

EID: 9444280101     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65705-7     Document Type: Article

References (23)

1. Melicow, M. M. and Hollowell, J. W.: Intra-urothelial cancer: carcinoma in situ, Bowen's disease of the urinary system: discussion of thirty cases. J. Urol., 68: 763, 1952.
2. Ortega, L. G., Whitmore, W. F., Jr. and Murphy, A. I.: In situ carcinoma of the prostate with intra-epithelial extension into the urethra and bladder; Paget's disease of the urethra and bladder. Cancer, 6: 898, 1953.
3. Karpas, C. M. and Moumgis, B.: Primary transitional cell carcinoma of prostate gland: possible pathogenesis and relationship to reserve cell hyperplasia of prostatic periurethral ducts. J. Urol., 101: 201, 1969.
4. Esrig, D., Elmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S. C., Nichols, P. W., Skinner, D. G., Jones, P. A. and Cote, R. J.: Accumulation of nuclear p53 and tumor progression in bladder cancer. New Engl. J. Med., 331: 1259, 1994.
5. Logothetis, C. J., Xu, H. J., Ro, J. Y., Hu, S. X., Sahin, A., Ordonez, N. and Benedict, W. F.: Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J. Natl. Cancer Inst., 84: 1256, 1992.
6. Schellhammer, P. F., Bean, M. A. and Whitmore, W. F., Jr.: Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis. J. Urol., 118: 399, 1977.
7. Wood, D. P., Jr., Montie, J. E., Pontes, J. E., Vanderburg Medendorp, S. and Levin, H. S.: Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. J. Urol., 141: 346, 1989.
8. Ende, N., Woods, L. P. and Shelley, H. S.: Carcinoma originating in ducts surrounding the prostatic urethra. Amer. J. Clin. Path., 40: 183, 1963.
9. Tannenbaum, M.: Transitional cell carcinoma of prostate. Urology, 5: 674, 1975.
10. Zincke, H., Utz, D. C. and Farrow, G. M.: Review of Mayo Clinic experience with carcinoma in situ. Urology, suppl. 4, 26: 39, 1985.
11. Matzkin, H., Soloway, M. S. and Hardeman, S.: Transitional cell carcinoma of the prostate. J. Urol., 146: 1207, 1991.
12. Hardeman, S. W. and Soloway, M. S.: Transitional cell carcinoma of the prostate: diagnosis, staging and management. World J. Urol., 6: 170, 1988.
13. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J. Amer. Stat. Ass., 53: 457, 1958.
14. Gaynor, J. J., Feuer, E. J., Tan, C. C., Wu, D. H., Little, C. R., Straus, D. J., Clarkson, B. D. and Brennan, M. F.: On the use of cause-specific failure and conditional failure probabilities: examination from clinical oncology data. J. Amer. Stat. Ass., 88: 400, 1993.
15. Jewett, H. J. and Strong, G. H.: Infiltrating carcinoma of the bladder: relation of depth of penetration of the bladder wall to incidence of local extension and metastases. J. Urol., 55: 366, 1946.
16. Marshall, V. F.: The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J. Urol., 68: 714, 1952.
17. International Union Against Cancer: TNM Classification of Malignant Tumours, 3rd ed. Edited by M. H. Harmer. Geneva: International Union Against Cancer, 1978.
18. Pagano, F., Bassi, P., Drago Ferrante, G. L., Piazza, N., Abatangelo, G., Pappagallo, G. L. and Garbeglio, A.: Is stage PT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or non-contiguous involvement. J. Urol., 155: 244, 1996.
19. Hillyard, R. W., Jr., Ladaga, L. and Schellhammer, P. F.: Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin. J. Urol., 139: 290, 1988.
20. Bretton, P. R., Herr, H. W., Whitmore, W. F., Jr., Badalament, R. A., Kimmel, M., Provet, J., Oettgen, H. F., Melamed, M. R. and Fair, W. R.: Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra. J. Urol., 141: 853, 1989.
21. Montie, J. E., Wood, D. P., Jr., Mendendorp, S. V., Levin, H. S. and Pontes, J. E.: The significance and management of transitional cell carcinoma of the prostate. Sem. Urol., 8: 262, 1990.
22. Wishnow, K. I. and Ro, J. Y.: Importance of early treatment of transitional cell carcinoma of prostatic ducts. Urology, 32: 11, 1988.
23. Laplante, M. and Brice, M., III: The upper limits of hopeful application of radical cystectomy for vesical carcinoma: does nodal metastasis always indicate incurability? J. Urol., 109: 261, 1973.